Meissner Corporation introduces the Automated Aliquoting System (AAS), a compact, recipe-driven platform that standardizes the transfer of bulk product with high accuracy into final single-use containers of all sizes, automating one of the remaining operator-dependent steps in single-use biomanufacturing.
Meissner Corporation will open its first dedicated Singapore office at Solaris @ one-north, a BCA Green Mark Platinum-certified building at 1 Fusionopolis Walk. The expansion strengthens Meissner’s Asia-Pacific presence, positioning the company closer to regional clients and partners. The move supports its long-term strategy of growing footprint in advanced manufacturing and innovation markets.
Meissner’s Unique Approach to Characterizing Its Ultrafiltration Membranes Results in
Lot-to-Lot Performance Consistency
Meissner’s Unique Approach to Characterizing Its Ultrafiltration Membranes Results in
Lot-to-Lot Performance Consistency
Upgrade your biomanufacturing operation with confidence: Meissner’s retrofit RMS mixing solutions empower Mobius Mix users to secure reliable, high-performance mixing—backed by Meissner’s trusted supply resilience and applications engineering. Discover how our innovative approach transforms risk into opportunity for biomanufacturers who demand more than just mixing.
Watch our presentation at the Biotech Week Boston 2023 conference on “An Improved Method of Characterization of Ultrafiltration (UF) Membranes for Bioprocessing”, given by Thomas D. Lazzara, Ph.D., Director of Research and Development. The characterization of ultrafiltration membranes with molecular weight (Mw) markers is a standard method to determine the retention rating of membranes in